TrialJournal of thrombosis and thrombolysis2009

Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy.

Victor Serebruany et al.PubMed ↗Publisher ↗

No numbers read from the abstract.